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Sunday, March 1, 2009 177aWe were further able to optically monitor the light-induced membrane depolar-
izations on a millisecond timescale with the voltage-sensitive RH421. The fluo-
rescence readout reflected the concentration-inhibition relationship of the
hKv1.5 inhibitor DPO-1.
LIVC represents a solely optical technology with remote activation of the target
voltage-gated ion channels simply by the delivery of a flash of blue light and
simultaneous detection of their activity employing voltage-sensitive dyes. It
combines the high-throughput of optical methods with the high-content of
patch clamp concerning and possible repetitive stimulation. Proof of concept
and results from assay development for voltage-gated sodium and calcium
channels as well as for the hERG channel underline the potential for LIVC
to evolve into a high-throughput, high reliability assay for voltage-gated ion
channels in general.
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We have examined the interactions of protons and an inhibitory, poly-cationic
conotoxin with the human voltage-gated potassium channel, hKv1.7. This
channel differs from somemembers of the Kv1 sub family by having a titratable
histidine residue near the N-terminal end of the putative pore-supporting P-he-
lix, suggesting that intrinsic channel functions and pharmacology may depend
on the pH of the external solution. Channels were expressed in HEK-293 cells
and studied by whole-cell patch clamp. The voltage dependence of channel ac-
tivation was evaluated using a tail-current protocol in which the voltage was
stepped to -40 mV following a variable activating pre-pulse. Lowering of the
pH of the external solution from 7.4 to 5.0 produced a positive shift in the
half-activation of 3653 mV (n¼4). The lowering of pH also dramatically de-
creased the ability of the conotoxin to inhibit currents through the channels.
Thus, following the largest depolarization, at pH5.0 very little inhibition was
observed at a toxin concentration near IC50 for pH7.4. The tail current in the
presence of the conotoxin was near the value seen in the absence of the toxin
for external pH of 7.4. Our observations are consistent with a two-fold action
of the conotoxin. First, they suggest that the positively charged toxin binds
close enough to the S4 segment of the voltage sensor to inhibit activation fol-
lowing a depolarizing voltage step. Second, the observed decrease in maximal
conductance at pH 7.4 following addition of the toxin is consistent with a block
of current through the open channels. Toxin binding appears to be inhibited by
protonation of a residue on the external surface of the channel, perhaps the his-
tidine residue near the N-terminal end of the pore helix.
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Pore Block of KCNQ1 Channels by Zn2þ is Modulated by Ancillary
Subunits
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The basolateral membrane Kþ channel, KCNQ1 (KvLQT1, Kv7.1), plays a crit-
ical role in anion secretion by gastrointestinal tissues because it establishes an
electrical driving force for anion exit. In secretory tissues, KCNQ1 associates
with the KCNE3 ancillary subunit to form a voltage-insensitive Kþ channel,
whereas, in the heart, it associates with KCNE1 (minK) to form a voltage-gated
channel. To demonstrate the role of KCNQ1 in anion secretion, we used forsko-
lin to activate secretory short circuit current (Isc) across T84 human colonic cell
monolayers. We demonstrate that addition of Zn2þ (5 mM), an inhibitor of in-
testinal secretion, to the serosal bath reduced Isc by 34%. Subsequent addition
of the Kþ channel blocker, Ba2þ (5 mM), reduced the current to near zero. To
determine the mechanisms of Zn2þ block, we expressed KCNQ1 in Xenopus
oocytes and determined the effects of extracellular Zn2þ on current-voltage re-
lationships. When KCNQ1 was co-expressed with KCNE1, Kþ currents were
very slowly voltage-activated and Zn2þ had a small inhibitory effect (23% at
Vm ¼ þ40 mV). Co-expression of KCNQ1 with KCNE3 resulted in Kþ cur-
rents that were constitutively active and voltage-insensitive, however, Zn2þ
caused these currents to become slowly-activating and dramatically reduced
(64%). The dose-inhibition curve for Zn2þ on KCNQ1 expressed with
KCNE1 revealed a single binding site (EC50 ¼ 2 mM). The curve for
KCNQ1 with KCNE3 also revealed a single binding component, but with
a much greater affinity (EC50 ¼ 0.1 mM) than we previously determined for
Ba2þ (EC50 ¼ 100 mM). These results suggest that the site of regulation of
the open or activated state of KCNQ1 by KCNE1 or KCNE3 involves the ex-
tracellular pore region. In addition, the ancillary subunits cause state-dependent
differences in the block of KCNQ1 by Zn2þ.916-Pos Board B795
Discovery of a Novel Activator of KCNQ1-KCNE1 Kþ Channel Com-
plexes
Karen Mruk, William R. Kobertz.
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KCNQ1 (Kv7.1) associates with the family of KCNE peptides to form com-
plexes with diverse gating properties and pharmacological sensitivities. The
varied gating properties of the different KCNQ1-KCNE complexes enables
the same Kþ channel to function in both excitable and non excitable tissues.
Small molecule activators would be valuable tools for examining the gating
mechanisms of KCNQ1-KCNE complexes; however, there are very few known
activators of KCNQ1 channels and most are ineffective on KCNQ1-KCNE
complexes. Our lab has identified a simple boronic acid, phenylboronic acid
(PBA), which potentiates KCNQ1-KCNE channel complexes in a voltage de-
pendent manner. Activation by the boronic acid moiety has some specificity for
the Kv7 family members (KCNQ1, KCNQ2/3, and KCNQ4) since PBA does
not activate Shaker or hERG channels. We show potentiation of current is
due to a slower rate of deactivation and a hyperpolarizing shift in the voltage
sensitivity of the channel complex. Analysis of different-sized charge carriers
revealed that PBA targets the permeation pathway of KCNQ1 channels. The
discovery that PBA activates physiologically relevant KCNQ1-KCNE com-
plexes makes it a useful and readily available tool to investigate the molecular
mechanisms of KCNQ1-KCNE complex activation.
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The KCNQ (Kv7) family of voltage gated ion channels conduct a number of hy-
perpolarising currents in various tissue types, including the heteromultimeric
KCNQ2/3 M-current found in sensory neurones. Cell lines constructed using
constitutive expression vectors to stably transfect KCNQ2/3, KCNQ4, and
KCNQ3/5 genes gave acceptable performance when using rubidium efflux
methodology. However, expression levels within the cell population were found
to be variable when assessed using conventional electrophysiology. Cell mor-
phology changed during passage and the cell lineswere unsuitable for automated
electrophysiology recording. Using RheoSwitch inducible vector technology
we have created new stable cell lines where the production of ion channel can be
closely controlled by addition of an inducer agent. Putative cloneswere screened
using IonWorks Quattro recording in single hole PatchPlate mode. For
each of the three cell lines, clones were identified displaying more than 60%
of the cells having greater than 0.5nA of current. The performance of the clones
in single hole mode was suitable for progression to Population Patch Clamp
(PPC) mode recording. Each cell line displayed acceptable seal properties and
current amplitudes, KCNQ2/3 2655 MU, 0.7750.19 nA (n¼250); KCNQ4
112549 MU, 0.4450.07 nA (n¼372) and KCNQ3/5 159544 MU,
0.8450.50 nA (n¼124). In addition, each cell line each cell line displayed the
appropriate pharmacology for regitabine, linopridine,XE991, TEAand bepridil.
The cell lines are suitable for compound screening and selectivity profiling using
automated and conventional electrophysiology.
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The neuronal subthreshold-operating A-type Kþ current regulates electrical ex-
citability, spike timing and synaptic integration and plasticity. The Kv4 chan-
nels underlying this current have been implicated in epilepsy, regulation of do-
pamine release, and pain plasticity. However, the unitary conductance (g) of
neuronal somatodendritic A-type Kþ channels composed of Kv4 pore-forming
subunits is larger (~7.5 pS) than that of Kv4 channels expressed singly in het-
erologous cells (~4 pS). Here, we examined the putative novel contribution of
the dipeptidyl-peptidase-like-protein-6 DPP6-S to the g of native (cerebellar
granule neuron, CGN) and reconstituted Kv4.2 channels. Co-expression of
Kv4.2 proteins with DPP6-S was sufficient to match the g of native CGN chan-
nels; and CGN Kv4 channels from dpp6 knock-out mice yielded a g indistin-
guishable from that of Kv4.2 channels expressed singly. Moreover, suggesting
electrostatic interactions, charge neutralization mutations of two N-terminal
178a Sunday, March 1, 2009acidic residues in DPP6-S eliminated the increase in g. Therefore, DPP6-S, as
a membrane protein extrinsic to the pore domain, is necessary and sufficient to
explain a fundamental difference between native and recombinant Kv4 chan-
nels. These observations may help to understand the molecular basis of neuro-
logical disorders correlated with recently identified human mutations in the
dpp6 gene.This work was supported by grants from the National Institutes of
Health (R01 NS032337-13 to MC; and NS045217 and NS30989 to BR).
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Recently we reported that the KCNE2 gene is an estrogen-responsive gene and
its transcripts are upregulated 6 fold by estrogen (E2) in ovariectomized (ovx)
mice1. We have also shown that cardiac Kv4.3 transcripts were downregulated
~2 fold by E22. As the effect of E2 treatment was more powerful on KCNE2 up-
regulation than Kv4.3 downregulation, we hypothesized that cardiac Kv4.3 and
KCNE2 have different sensitivities to heart E2 concentrations [E2]. We mea-
sured heart [E2] togetherwithKCNE2andKv4.3 transcript levels in 4 estrogenic
conditions: i) E2-depleted (anastrozole treatedmice, [E2]¼4.250.4 pg/ml n¼4;
ii) low E2 (ovx sham, [E2]¼1651.4 pg/ml n¼3 and diestrus [E2]¼20.251.5
n¼4), iii) intermediate E2 (male [E2]¼3553 pg/ml, n¼6) and iv) high E2
(ovxmice treatedwith E2, [E2]¼62.752.9 pg/ml, n¼3). Kv4.3 transcript levels
were not affected by heart [E2] lower than 35 pg/ml whereas KCNE2 transcript
levelswere very sensitive to this range of heart [E2], reaching a ~10 fold increase
from low to intermediate heart [E2], saturating at 35 pg/ml. The fact that Kv4.3
levels were unaffected by anastrozole treatment, whereas KCNE2 levels were
dramatically reduced by ~8 fold by anastrozole, further supports the finding
that KCNE2 upregulation can take place at very low E2 levels. The downregu-
lation of Kv4.3 transcripts were only evident at high estrogenic conditions,
whereas KCNE2 remains at its maximum. As Kv4.3 is one of the molecular
correlate of Ito,f and it has also been shown that KCNE2 can potentiate Kv4.3
currents in the expression system, we speculate that the relative expression of
KCNE2 and Kv4.3 as defined by heart [E2] will determine Ito,f amplitude.
1. Kundu et al., Mol Cell Endocrinol 2008;292:50-62.
2. Eghbali et al., Circ Res 2005;96:1208-16.
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Vernakalant, a relatively atrial selectivemixed ion channel blocker, rapidly con-
verts atrial fibrillation to normal sinus rhythm in humans. Previous studies dem-
onstrated that vernakalant blocks Kv4.3 but the state dependence of blockade
and influenceofKChIP2were not determined.Kv4.35KChIP2was transfected
in HEK cells and currents were recorded by whole-cell voltage clamp.
Measured activation and inactivation kinetics and voltage dependence was con-
sistent with current models of closed, open, open-inactivated, and closed-inacti-
vated states. Vernakalant, with little effect on peak current (tact ¼ 0.395 0.02
ms), induced a very rapid initial decay (tass ¼ 3.905 0.21 ms) followed by the
well-described fast (tfast¼ 39.95 4.1ms) and slow (tslow¼ 1935 22ms) com-
ponents of steady state inactivation. This indicates that vernakalant rapidly asso-
ciates with the open state causing block (IC50 ¼ 23.05 5.1 mM). Tail currents
following short periods of depolarization (þ10mv, 10ms) insufficient to induce
inactivation, initially decayedmore rapidly in the presence of vernakalant. How-
ever the slow time constant (tdiss¼ 33.15 5.9 ms, n¼2) was much longer than
deactivation (tdeact¼ 14.85 1.8 ms, n¼2) leading to crossover of tail currents.
Thus, vernakalant rapidly associated with the open state to produce a drug
blocked state and less rapidly dissociated back to the open state, which then de-
activated to the closed state. Vernakalant did not affect recovery from inactiva-
tion. Co-expression with KChIP2 did not affect vernakalant’s potency (IC50 ¼
22.35 4.7 mM). This is consistent with previous studies showing that KChIP2
modulates inactivation kinetics with little effect on activation kinetics.
In conclusion, vernakalant rapidly blocks Kv4.3 in the open state and KChIP2
does not modulate the Kv4.3 block by vernakalant.
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In the absence of external Kþ, external Naþ (Naþo) inhibited the human ether-a-
go-go-related gene (hERG)-encoded channel Kþ current (IhERG-K) with an IC50
of 4.45 0.7mM, andNaþ current (IhERG-Na) with an IC50 of 3.55 0.4mM (P>0.05). Using the whole cell patch clamp and site-directed mutagenesis methods
on recombinant hERG channels, we found that Naþo-induced inhibition of
hERG current was intrinsically independent of either activation or inactivation
of the channel. In the absence ofKþ, Naþo inhibited IhERG-Na in a time-dependent
manner with a time constant of 15.05 0.4 s. The recovery of IhERG-Na from in-
hibition after washout of Naþo was also time dependent, with a time constant of
27.15 1.0 s. Kþ competeswithNaþ for binding to interfere withNaþomediated
inhibitionof hERGchannels.When IhERG-Kwasmaximally inhibited by135mM
Naþo, outflowingK
þ during channel opening dynamically relivedNaþo-induced
inhibition. As well, addition of Kþ to the 135mMNaþ-containing bath solutions
relieved the Naþo-mediated inhibition of IhERG-K with an EC50 of 1.2 mM. Point
mutations in the hERG pore region were identified to completely eliminate
hERG Naþ sensitivity. We propose that Kþo and Na
þ
o compete for a binding
site(s) close to the permeation pathway of the channel to determine the fate of
hERG function.While Kþ-bound hERG channels gate normally, Naþ-bounding
fosters the hERG channel entering into a nonfunctional conformation.
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Papaverine, a vasodilator used as a therapeutic agent for a range of diseases, has
been reported to increase the risk of occasional serious ventricular arrhythmias.
To examine the mechanism for this effect, we herein tested the effects of papav-
erine on human ether-a-go-go (HERG) Kþ channels expressed in HEK293
cells and Xenopus oocytes. Our results revealed that papaverine dose-depen-
dently decreased the tail currents of HERG channel expressed in HEK293 cells
with the IC50 and the Hill coefficient of 0.58 mM and 0.58, respectively, at þ20
mV and 36 C. The IC50 for the papaverine-induced blockade of HERG current
in Xenopus oocytes was found to decrease progressively relative to depolariza-
tion (38.8, 30.0, and 24.8 mM at -10, þ20, and þ40 mV, respectively). The
papaverine-induced blockade of HERG current was time-dependent; the frac-
tional current was 0.92 5 0.03 of the control at the beginning of the pulse,
but declined to 0.185 0.06 after 6 seconds at a test potential of 0 mV. These
results collectively indicate that papaverine blocks HERG channel in a concen-
tration-, voltage-, and time-dependent manner. Two S6 domain mutations,
Y652A and F656A, partially attenuated (Y652A) or abolished (F656A) the
hERG current blockade, suggesting that papaverine blocks HERG channel at
the pore of the channel. This was consistent with the computational simulation
that showed papaverine interacts with Tyr652 and Phe656. Therefore, ventric-
ular arrhythmias induced by papaverine could be resulted from the blockage of
the HERG channel at the cardiac myocytes.
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Block of the cardiac potassium channel HERG by a number of drugs has been
shown by different investigators to depend on the extracellular potassium con-
centration. This dependency on extracellular potassium can be explained by at
least two mechanisms: destabilization of the drug by the permeant ion or differ-
ential binding to the inactivated state. We previously reported that block of
HERG by terfenadine shows the opposite dependency on extracellular potas-
sium compared to quinidine. Thus HERG block by quinidine is greater in
0 mM K compared to 20 mM K whereas block by terfenadine is greater in 20
mM K compared to 0 mM K. In order to determine the mechanism underlying
this difference in potassium dependency we measured block by terfenadine of
theHERGmutantD540Kwhich openswith both depolarization and hyperpolar-
ization. Block of D540K by terfenadine showed the opposite dependency on ex-
tracellular potassium compared to block of WT HERG by terfenadine. Thus
block of D540Kby terfenadine is greater in 0mMK compared to 20mMK, sim-
ilar to the extracellular potassium dependency of block of WT HERG by quini-
dine. Recent experiments indicate that terfenadine is trapped inside the channel
after the channel closes, whereas quinidine is not1. In addition we have reported
that block of HERG by quinidine shows a better correlation with the permeant
ion than with inactivation. Together these results suggest that the permeant
ion is not able to destabilize a trapped drug but is able to destabilize a drug
that is not trapped and indicate a possible role for the activation gate in determin-
ing the extracellular potassium dependency of block of HERG.
1 Stork et al. (2007) BJP 151:1368-1376.
